Machine Learning

A promising fintech's complex arbitrage strategy collapses, triggering a stock crash, CEO exit, and a wave of securities fraud investigations.

Mouser Electronics' sponsorship of DS PENSKE is more than a logo on a car. It’s a strategic investment in the future of EV tech and sustainable innovation.

At Riyadh's Black Hat MEA, Resecurity is leveraging AI and Dark Web intelligence in a high-stakes play for the booming Middle East cybersecurity market.

The PAS 2026 meeting is more than a conference; it's a convergence of science, capital, and community, signaling major shifts in pediatric care.

A strategic alliance between ServiceNow and MeasureUp aims to end the 'wild west' of exam prep, reshaping careers and the enterprise tech ecosystem.

How Winemaker of the Year Jesse Katz blends record-setting sales, historic vineyards, and philanthropy to disrupt the ultra-premium wine market.

Abbott launches two new Ensure shakes, using science and tech to frame muscle health as the key to a longer, stronger life. Is protein the new longevity drug?

A routine financial disclosure from an asset manager unveils Qualcomm's $2.4B bet on Alphawave, signaling a major push into the AI infrastructure that powers health tech.

New AI summarization tools promise to conquer information overload, but their adoption in defense and aerospace hinges on trust, security, and human oversight.

A landmark deal between a defense giant and a tech titan is set to revolutionize space operations. Here's why the future of national security is in the cloud.

A new AI-powered platform, CrossSight, promises to deliver audit-ready due diligence reports in minutes, tackling critical third-party security risks.

For the third straight year, Rate Insurance made the industry's top list. We dive into the tech, strategy, and customer focus fueling its disruption.

From AI-powered planning to exclusive lounges and hidden gem destinations, discover the trends reshaping how we'll travel and spend in 2026.

A strategic partnership integrates cutting-edge AI into drug development, promising to slash timelines and costs. Is this the new blueprint for pharma R&D?

With new EHR integrations and a direct-to-provider model, Speke AI is making its ambient intelligence tools more accessible than ever. Is this the tipping point?